Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib vs aceclofenac + ilaprazole for NSAID-induced dyspepsia
KCT0004786Phase 4Completed
- Sponsor
- Il-Yang Pharmaceutical
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of celecoxib, aceclofenac, ilaprazole in rheumatoid arthritis (RA), osteoarthritis (OA), dyspepsia, sponsored by Il-Yang Pharmaceutical. Started Apr 2020; status: completed.
02
Drugs
celecoxibaceclofenacilaprazole
03
Conditions
rheumatoid arthritis (RA)osteoarthritis (OA)dyspepsia
Beyond the preview
Go deeper on KCT0004786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004786.